Caitlin Cronin
Stock Analyst at Canaccord Genuity
(2.01)
# 2,979
Out of 4,886 analysts
29
Total ratings
36.36%
Success rate
-0.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ENOV Enovis | Maintains: Buy | $75 → $70 | $34.74 | +101.50% | 2 | May 14, 2025 | |
AXGN Axogen | Maintains: Buy | $26 → $24 | $11.48 | +109.06% | 6 | May 13, 2025 | |
SNN Smith & Nephew | Maintains: Hold | $27 → $28 | $29.77 | -5.95% | 2 | May 1, 2025 | |
INMD InMode | Maintains: Hold | $17 → $15 | $15.36 | -2.34% | 3 | Apr 29, 2025 | |
TELA TELA Bio | Maintains: Buy | $12 → $7 | $1.98 | +253.54% | 4 | Mar 21, 2025 | |
BVS Bioventus | Maintains: Buy | $15 | $7.07 | +112.16% | 1 | Mar 17, 2025 | |
VCEL Vericel | Maintains: Buy | $64 → $67 | $40.17 | +66.79% | 3 | Feb 3, 2025 | |
KRMD KORU Medical Systems | Maintains: Buy | $3 → $4 | $3.80 | +5.26% | 2 | Nov 14, 2024 | |
ATEC Alphatec Holdings | Maintains: Buy | $20 | $11.60 | +72.41% | 3 | Aug 30, 2024 | |
ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $93.47 | +39.08% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $79 | $56.60 | +39.58% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $7.72 | +55.44% | 1 | Nov 14, 2023 |
Enovis
May 14, 2025
Maintains: Buy
Price Target: $75 → $70
Current: $34.74
Upside: +101.50%
Axogen
May 13, 2025
Maintains: Buy
Price Target: $26 → $24
Current: $11.48
Upside: +109.06%
Smith & Nephew
May 1, 2025
Maintains: Hold
Price Target: $27 → $28
Current: $29.77
Upside: -5.95%
InMode
Apr 29, 2025
Maintains: Hold
Price Target: $17 → $15
Current: $15.36
Upside: -2.34%
TELA Bio
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $7
Current: $1.98
Upside: +253.54%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $7.07
Upside: +112.16%
Vericel
Feb 3, 2025
Maintains: Buy
Price Target: $64 → $67
Current: $40.17
Upside: +66.79%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $3.80
Upside: +5.26%
Alphatec Holdings
Aug 30, 2024
Maintains: Buy
Price Target: $20
Current: $11.60
Upside: +72.41%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $93.47
Upside: +39.08%
Feb 21, 2024
Reiterates: Buy
Price Target: $79
Current: $56.60
Upside: +39.58%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $7.72
Upside: +55.44%